Slideshow

You Spoke, We Listened. Psychiatry's Cannabis Survey

Author(s):

Psychiatric Times Editors

Enlightening survey results reveal what psychiatrists think about medical marijuana/cannabis use, how or whether to discuss with their patients, and what biases might get in the way of such conversations.

Related Videos
emergency
peshkova Adobestock
schizophrenia
clozapine
brain
Related Content
Study Finds Zuranolone Effective for Anhedonia in Patients With PPD
May 20th 2025

Study Finds Zuranolone Effective for Anhedonia in Patients With PPD

Heidi Anne Duerr, MPH
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
Brigitte Robertson, MD
May 13th 2025

Combating Misconceptions About Alcohol Use Disorder: In Conversation With Brigitte Robertson, MD

Leah Kuntz Brigitte Robertson, MD
How to Talk to Teenagers About Substance Use
October 8th 2021

How to Talk to Teenagers About Substance Use

Hannah Simon, MD
alcohol refusal
May 8th 2025

FDA Has Granted Request for End of Phase 2 Meeting to Discuss Alcohol Use Disorder Treatment, AD04

Leah Kuntz
The “DIY” Psychiatry Movement: A Potential Threat to Patient Welfare and Well-Being
May 5th 2025

The “DIY” Psychiatry Movement: A Potential Threat to Patient Welfare and Well-Being

Katherine Ponte, JD, MBA Joseph F. Goldberg, MD
© 2025 MJH Life Sciences

All rights reserved.